ライフサイエンスコーパス: C. guilliermondii

1 sis; 16 (100%), 4 (95.5%), and 4 (98.9%) for C. guilliermondii.

2 r more of the echinocandins, most (68%) were C. guilliermondii.

3 e not significantly different from those for C. guilliermondii.

4 ogy and antifungal susceptibility profile of C. guilliermondii.

5 is to 100% for C. krusei, C. lusitaniae, and C. guilliermondii.

6 ranged from 0% for C. lusitaniae to 100% for C. guilliermondii.

7 or C. glabrata to 100% for C. lusitaniae and C. guilliermondii.

8 .0), 1 (92.7)/-, and 1 (100.0)/2 (100.0) for C. guilliermondii.

9 0.12; for C. lusitaniae, 0.03 and 0.007; for C. guilliermondii, 0.12 and 0.03; and for C. kefyr, 0.06

10 3/0.06, 99.7; C. krusei, 0.12/0.5, 99.0; and C. guilliermondii, 0.5/1, 94.4.

11 ; C. kefyr, 0.06/0.06; C. parapsilosis, 1/2; C. guilliermondii, 0.5/1; C. lusitaniae, 0.12/0.25; othe

12 ), 8 (95.0), 0.5 (97.5), and 0.25 (98.0) for C. guilliermondii; 0.25 (98.9), 0.03 (98.0), 0.12 (97.5)

13 67 isolates of C. lusitaniae, 48 isolates of C. guilliermondii, 10 isolates of C. famata, 10 isolates

14 mong the emerging fluconazole-R species were C. guilliermondii (11.4% R), C. inconspicua (53.2% R), C

15 mutant strain), 25 of C. parapsilosis, 19 of C. guilliermondii, 12 of C. tropicalis (2 mutant strains

16 ng methods demonstrated that 19 strains were C. guilliermondii, 14 were C. parapsilosis, 5 were C. lu

17 abrata (2 fluconazole-resistant isolates), 5 C. guilliermondii (2 fluconazole-resistant isolates), 10

18 olates were C. parapsilosis, 6 isolates were C. guilliermondii, 2 isolates were C. rugosa, and 1 isol

19 97%; C. glabrata, 93%; C. parapsilosis, 85%; C. guilliermondii, 83%; and C. lusitaniae, 50%.

20 for C. krusei, 100%, 100%, and 100%; and for C. guilliermondii, 90.2%, 95.1%, and 100%.

21 C. guilliermondii, a species that exhibits reduced susce

22 C. guilliermondii and C. rugosa were most prominent in L

23 . lusitaniae, 0.5 (98.9) and 0.25 (98.3) for C. guilliermondii, and 0.25 (100.0) and 0.015 (100.0) fo

24 labrata, 12% C. tropicalis, 3% C. krusei, 1% C. guilliermondii, and 2% other Candida spp.

25 2.0% were due to C. krusei, 0.7% were due to C. guilliermondii, and 5.8% were due to Candida spp.

26 picalis, 270 C. krusei, 99 C. lusitaniae, 88 C. guilliermondii, and 61 C. kefyr isolates) were obtain

27 5 isolates of C. lusitaniae, 177 isolates of C. guilliermondii, and 93 isolates of C. kefyr were obta

28 % for C. krusei to 100% for C. parapsilosis, C. guilliermondii, and C. lusitaniae.

29 Others (C. lusitaniae, C. guilliermondii) are haploid, and their mating produce

30 rved in strains of C. krusei, C. lusitaniae, C. guilliermondii, C. inconspicua, and C. sake.

31 to detect seven additional Candida species (C. guilliermondii, C. kefyr, C. lambica, C. lusitaniae,

32 lates include Candida krusei, C. lusitaniae, C. guilliermondii, C. kefyr, C. rugosa, C. lipolytica, C

33 to 100% for C. tropicalis, C. parapsilosis, C. guilliermondii, C. krusei, and C. lusitaniae.

34 , C. parapsilosis, C. krusei, C. lusitaniae, C. guilliermondii, C. lipolytica, C. rugosa, and C. zeyl

35 nce over time was seen with C. parapsilosis, C. guilliermondii, C. lusitaniae, C. sake, and C. pellic

36 ion and antifungal susceptibilities of 1,029 C. guilliermondii clinical isolates collected from 127 m

37 tion, with some species (e.g., C. rugosa and C. guilliermondii) demonstrating reduced susceptibilitie

38 C. guilliermondii grows poorly under anaerobic condition

39 tropicalis in 9%, C. parapsilosis in 3%, and C. guilliermondii in 3%.

40 r, extensive environmental sampling revealed C. guilliermondii in an anaerobic holding jar in the cli

41 A molecular evaluation of the C. guilliermondii isolates confirmed a common source for

42 increasing azole resistance over time among C. guilliermondii isolates tested from 2001 to 2003.

43 C. krusei (n = 143), C. lusitaniae (n = 54), C. guilliermondii (n = 39), C. pelliculosa (n = 17), C.

44 C. parapsilosis (n = 39), C. krusei (n = 5), C. guilliermondii (n = 6), and C. lusitaniae (n = 2).

45 . krusei (n = 5), C. lusitaniae (n = 2), and C. guilliermondii (n = 6).

46 15 with low confidence between C. famata and C. guilliermondii or C. parapsilosis, displaying only 56

47 C. guilliermondii represented 1.4% of the 75,761 isolate

48 C. tropicalis, C. krusei, C. lusitaniae, and C. guilliermondii) simultaneously with very high specifi

49 Of 132 bloodstream isolates of C. guilliermondii tested against caspofungin, most were

50 oriconazole was more active in vitro against C. guilliermondii than fluconazole (91% susceptible; ran

51 usceptibility of 132 bloodstream isolates of C. guilliermondii to caspofungin.

52 lbicans, C. parapsilosis, C. tropicalis, and C. guilliermondii were all highly susceptible to both fl

53 ml), and C. parapsilosis, C. lusitaniae, and C. guilliermondii were the least susceptible (MIC(90), 0

54 rapsilosis and variants of C. lusitaniae and C. guilliermondii were the most resistant, demonstrating